On the other hand, a person with more muscle mass may require a slightly longer needle for an intramuscular shot to reach the muscle effectively
Reported or proposed issue Pregnancy, breastfeeding, children, liver disease, or cancer history Evidence source No direct human safety data Known or theoretical
This compound is not intended for therapeutic or diagnostic purposes and has not been evaluated by regulatory agencies for safety or efficacy in humans
FDA found online marketing for sleep disorders, stress reduction, pain, cancer, neurodegenerative conditions and substance withdrawal
Symptoms of deficiency include fatigue, weakness, neurological problems (such as paraesthesia, balance difficulties, and cognitive impairment), and megaloblastic anaemia
The compound is referenced across a wide spectrum of preclinical models, with most literature focusing on three thematic areas: The 50mg and 100mg vial formats make GHK-Cu particularly suitable for extended research protocols where higher peptide volumes are required compared with the typical 510mg formats used for other research compounds